Acambis (India) Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Karnal, Haryana, India, established in 2016.
2016 Karnal, Haryana, India Dormant Under Section 455
Last Updated:
Access Report
About Acambis (India) Pharmaceuticals Private Limited

Acambis (India) Pharmaceuticals Private Limited, a dormant under section 455 private limited company, was established on 23 February 2016 in Karnal, Haryana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100HR2016PTC058332. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nathi Ram (Director), Mamta Devi (Director). It is based at S-8, 1St Floor Rajiv Gandhi, Karnal, Haryana, 132001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100HR2016PTC058332

  • Registration Number

    058332

  • Incorporation Date

    23 February 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Dormant Under Section 455

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 10 Days
Company report

Acambis (India) Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Acambis (India) Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Acambis (India) Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nathi Ram Director 23 Feb 2016 Current
Mamta Devi Director 23 Feb 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acambis (India) Pharmaceuticals.

Enhance accessibility to Acambis (India) Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Acambis (India) Pharmaceuticals revenue growth over time
Acambis (India) Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acambis (India) Pharmaceuticals?

Unlock access to Acambis (India) Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Acambis (India) Pharmaceuticals?

Unlock and access historical data on people associated with Acambis (India) Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acambis (India) Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acambis (India) Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acambis (India) Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Nathi Ram was appointed as a Director was appointed as a Director on 23 Feb 2016 & has been associated with this company since 10 years 10 days . was completed.

  • Director Appointment

    Mamta Devi was appointed as a Director was appointed as a Director on 23 Feb 2016 & has been associated with this company since 10 years 10 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Acambis (India) Pharmaceuticals Private Limited was registered on 23 Feb 2016 with Roc Delhi & aged 10 years 10 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Acambis (India) Pharmaceuticals Private Limited?

The CIN of Acambis (India) Pharmaceuticals Private Limited is U24100HR2016PTC058332.

Where is Acambis (India) Pharmaceuticals Private Limited headquartered?

Acambis (India) Pharmaceuticals Private Limited is headquartered at S-8, 1St Floor Rajiv Gandhi, Karnal, Haryana, 132001.

When was Acambis (India) Pharmaceuticals Private Limited incorporated?

Acambis (India) Pharmaceuticals Private Limited was incorporated on 23 February 2016.

Who are the current directors of Acambis (India) Pharmaceuticals Private Limited?

The current directors of Acambis (India) Pharmaceuticals Private Limited are

What is the primary industry of Acambis (India) Pharmaceuticals Private Limited?

The primary industry of Acambis (India) Pharmaceuticals Private Limited is Chemicals.

Is Acambis (India) Pharmaceuticals Private Limited a listed company?

Acambis (India) Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Acambis (India) Pharmaceuticals Private Limited?

The authorized capital of Acambis (India) Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available